| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/04/2004 | WO2004018482A2 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | US20040044014 Controlling signal transduction; tyrosine kinase inhibitors; benign prostatic hyperplasmia; respiratory system disorders; antitumor agents |
| 03/04/2004 | US20040043991 Antiarthritic agents; anticancer agents; antiinflammatory agents |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043988 Cycloalkyl alkanoic acids as intergrin receptor antagonists |
| 03/04/2004 | US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 03/04/2004 | DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
| 03/03/2004 | EP1394240A1 Bicyclic thioamides as additives for lubricating oils |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1392870A1 Screening for enzyme inhibitors |
| 03/03/2004 | EP1392702A1 Compounds and methods for inhibiting mrp1 |
| 03/03/2004 | EP1392701A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
| 03/03/2004 | EP1392700A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 03/03/2004 | EP1392699A1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/03/2004 | EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392294A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/03/2004 | EP1282624B1 Crf receptor antagonists and methods relating thereto |
| 03/03/2004 | EP1087780B1 Extraction method of a compound from vegetable material |
| 03/03/2004 | EP0788500B1 PROCESSES AND INTERMEDIATES FOR PREPARING 5,7-DIHYDRO-3- 2- 1-BENZYLPIPERIDIN-4-YL ETHYL]-6H-PYRROLO- 4,5-f]-1,2-BENZISOXAZOL-6-ONE |
| 03/03/2004 | CN1479742A Process for preparing substance GM-95 |
| 03/03/2004 | CN1140528C Process for preparation of herbicidal derivatives |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/02/2004 | US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/02/2004 | US6699897 Streptogramin derivatives, their preparation and compositions which contain them |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 03/02/2004 | US6699852 Substituted pyridoindoles as serotonin agonists and antagonists |
| 02/26/2004 | WO2004016621A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 02/26/2004 | WO2004016614A2 Pyrrolopyrazines as kinase inhibitors |
| 02/26/2004 | WO2003090684A3 Polymer compositions containing a macrocyclic triene compound |
| 02/26/2004 | US20040039209 Compounds containing oxazolidinone moiety and uses thereof |
| 02/26/2004 | US20040039199 4-((3-(7-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo(3.3. 1)non-3-yl)propyl))amino)benzonitrile, benzenesulfonic acid salt, is useful in the prophylaxix |
| 02/26/2004 | US20040039197 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
| 02/26/2004 | US20040039012 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038987 Novel cyclic diamine compounds and medicine containing the same |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038975 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | US20040038882 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390372A1 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 02/25/2004 | EP1390371A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 02/25/2004 | EP1390370A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1206469B1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 02/25/2004 | CN1478136A Novel red fluorescent material and organic electroluminescent device containing same |
| 02/25/2004 | CN1478096A L-nucleic acid derivatives and processes for synthesis thereof |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1139595C Crystalline macrolides and its preparation method |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | CA2438001A1 Use of the disorazoles and their derivatives for the treatment of benign and malignant oncoses |
| 02/19/2004 | WO2004015119A2 Methods for the isolation and purification of ansamitocins |
| 02/19/2004 | WO2004014923A1 Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014908A1 Heterobicylcic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014893A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | WO2004014868A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2004014354A1 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014222A2 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | WO2003045329A3 Methods for the purification of levofloxacin |
| 02/19/2004 | US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 02/19/2004 | US20040034081 Estrogen receptor modulators |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034021 Intravenous rifalazil formulation and methods of use thereof |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034009 1,6-Fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | US20040033910 Bicyclic thioamides as additives for lubricating oils |
| 02/19/2004 | DE10234697A1 Neue Verbindungen zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Novel compounds for stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 02/19/2004 | CA2497656A1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2495085A1 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | CA2493146A1 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/18/2004 | EP1389213A1 3,7-diazabicyclo 3.3.1] formulations as antiarhythmic compounds |
| 02/18/2004 | EP1389212A1 3,7-diazabicyclo 3.3.1] formulations as anti-arrythmic compounds |
| 02/18/2004 | EP1389211A1 3,7-diazybicyclo 3.3.1] formulations as antiarrhytmic compounds |
| 02/18/2004 | EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
| 02/18/2004 | EP1389091A1 Granular preparations of gaboxadol |
| 02/18/2004 | EP1213281B1 Novel amide derivatives |
| 02/18/2004 | EP1181295B1 Tricyclic benzoylcyclohexanedione derivatives |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP0944627B1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 02/18/2004 | EP0839134B1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693192 Hypolipidemic and antioxidant morpholine derivatives |
| 02/17/2004 | US6693189 Materials and method for treating or preventing pathogenic fungal infection |
| 02/17/2004 | US6693109 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 02/17/2004 | US6693101 Alkanoic acid derivative; integrin receptor antagonist |
| 02/12/2004 | WO2004013300A2 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 02/12/2004 | WO2004013235A1 Fibre-reactive azo dyes, their preparation and their use |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2004012649A2 Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003035652A8 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES |